Clinical trial
Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute…
NCT00357084 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00357084 |
|---|---|
| Title | Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant |
| Official title | A Phase II Study to Evaluate Efficacy and Tolerability of Methotrexate in Combination With Glucocorticoids for the Treatment of Newly Diagnosed Acute Graft-Versus-Host Disease After Nonmyeloablative Hematopoietic Cell Transplantation |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | methotrexate, methylprednisolone, prednisone |
| Enrollment | 53 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2007 |
| First posted | Jul 27, 2006 |
| Last update posted | Sep 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: